OBJECTIVES: Staphylococcus aureus bacteremia (SAB) is one of the most frequent bloodstream infections. High mortality of SAB can be significantly reduced by regular infectious disease (ID) consultations and appropriate clinical management. Because the pandemic of coronavirus disease 2019 (COVID-19) has had a negative impact on hospital ID service, it can be assumed that it has also led to decreased quality of care for SAB patients. METHODS: This study enrolled all (n = 68) patients with proven SAB who were hospitalized in Military University Hospital, Prague, in 2019 and 2020 and the quality of care indicators for SAB patients were compared. RESULTS: A total of 33 and 35 patients with SAB were hospitalized in our hospital in 2019 and 2020, respectively. The significant difference between the pandemic year 2020 and year 2019 was in ID consultations performed (74% vs. 100%; p = 0.002) and fulfilment of all quality of care indicators (66% vs. 93%; p = 0.012). Next, higher in-hospital mortality was observed in 2020 than in 2019 (6% vs. 23%; p = 0.085). There was no significant difference in the percentages of patients with performed echocardiographic examinations (66% vs. 83%; p = 0.156) and collected follow-up blood cultures (85% vs. 94%; p = 0.428). In addition, there was no difference between the two years in the adequate antibiotic therapy, sources, and bacterial origin of SAB. CONCLUSIONS: The quality of care of SAB patients significantly decreased during the COVID-19 pandemic in our institution.

Department of Infectious Diseases 1st Faculty of Medicine Charles University and Military University Hospital Prague U Vojenské nemocnice 1200 169 02 Prague 6 Czech Republic

Department of Orthopedics 1st Faculty of Medicine Charles University and Military University Hospital Prague Prague Czech Republic

Zobrazit více v PubMed

Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG., Jr Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–661. doi: 10.1128/CMR.00134-14. PubMed DOI PMC

Vogel M, Schmitz RP, Hagel S, Pletz MW, Gagelmann N, Scherag A, et al. Infectious disease consultation for Staphylococcus aureus bacteremia—a systematic review and meta-analysis. J Infect. 2016;72(1):19–28. doi: 10.1016/j.jinf.2015.09.037. PubMed DOI

Forsblom E, Kakriainen A, Ruotsalainen E, Jarvinen A. Methicillin-sensitive Staphylococcus aureus bacteremia in aged patients: the importance of formal infectious specialist consultation. Eur Geriatr Med. 2018;9(3):355–363. doi: 10.1007/s41999-018-0038-2. PubMed DOI PMC

Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SM, et al. Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open. 2014;2(4):E352–E359. doi: 10.9778/cmajo.20140018. PubMed DOI PMC

van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012;25(2):362–386. doi: 10.1128/CMR.05022-11. PubMed DOI PMC

Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53–59. doi: 10.1086/345476. PubMed DOI

Ten Oever J, Jansen JL, van der Vaart TW, Schouten JA, Hulscher M, Verbon A. Development of quality indicators for the management of Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019;74(11):3344–3351. doi: 10.1093/jac/dkz342. PubMed DOI PMC

Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451–1461. doi: 10.1093/cid/civ120. PubMed DOI

Arientova S, Beran O, Stefan M, Curdova M, Holub M. Bacteremia due to Staphylococcus aureus—the importance of appropriate management. Epidemiol Mikrobiol Imunol. 2018;67(2):88–91. PubMed

Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J, Bereciartua-Bastarrica E, Farinas MC, Sanz-Franco M, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57(9):1225–1233. doi: 10.1093/cid/cit499. PubMed DOI

Martin L, Harris MT, Brooks A, Main C, Mertz D. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study. BMC Infect Dis. 2015;15:568. doi: 10.1186/s12879-015-1296-y. PubMed DOI PMC

Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2019;2021:1–14. PubMed

Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N, et al. The impact of COVID-19 on healthcare-associated infections. Clin Infect Dis. 2021 doi: 10.1093/ofid/ofab466.171. PubMed DOI PMC

Holland TL, Arnold C, Fowler VG., Jr Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014;312(13):1330–1341. doi: 10.1001/jama.2014.9743. PubMed DOI PMC